Financial statements Imunotop Pl

Balance sheet of Imunotop Pl

Company age:
Age:
22 y. 8 m. 25 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of IMUNOTOP PL

Year
2018
2019
2020
2021
2022
Total assets 321 114,71 244 024,85 282 968,40 219 287,11 231 117,67
A. Fixed assets 56 334,41 44 936,57 31 663,69 22 233,37 12 803,05
B. Current assets 264 780,30 199 088,28 251 304,71 197 053,74 218 314,62
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 321 114,71 244 024,85 282 968,40 219 287,11 231 117,67
A. Equity 163 710,51 83 186,22 53 714,15 52 015,90 52 160,76
B. Liabilities and provisions for liabilities 157 404,20 160 838,63 229 254,25 167 271,21 178 956,91
I. Long-term liabilities - - - - -
II. Short-term liabilities 157 404,20 160 838,63 229 254,25 167 271,21 178 956,91
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.